Shares of Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) reached a new 52-week high on Thursday . The company traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares traded. The stock had previously closed at $75.00.
Analysts Set New Price Targets
Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.
Check Out Our Latest Stock Report on PHMMF
Pharma Mar Stock Performance
Pharma Mar Company Profile
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
See Also
- Five stocks we like better than Pharma Mar
- Upcoming IPO Stock Lockup Period, Explained
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- ETF Screener: Uses and Step-by-Step Guide
- Time to Load Up on Home Builders?
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
